Ge Healthcare Technologies INC 8-K filings
NASDAQ
Jan Makela, Chief Executive Officer of Imaging at GE HealthCare Technologies Inc., has resigned effective July 8, 2024, to take a CEO position at a private company.
NASDAQ
GE HealthCare has announced the pricing of a secondary offering of 14 million shares of its common stock, with General Electric expected to exchange the shares for debt.
NASDAQ
GE HealthCare has announced a secondary offering of 13 million shares of its common stock, with General Electric Company (GE) expected to exchange the shares for debt held by Morgan Stanley.
NASDAQ
8-K/A: GE HealthCare Reports Strong First Year as Public Company with Solid Q4 and Full Year 2023 Results
GE HealthCare reported a 5% year-over-year revenue growth for the fourth quarter of 2023 and 7% for the full year, marking a strong first year as a public company.
NASDAQ
8-K/A: GE HealthCare Reports Strong First Year as Public Company with Solid Q4 and Full Year 2023 Results
GE HealthCare reported a 5% year-over-year revenue growth for the fourth quarter of 2023 and 7% for the full year, marking a strong first year as a public company.
NASDAQ
8-K: GE HealthCare Reports Strong First Year Results as Public Company, Provides Positive 2024 Outlook
GE HealthCare announced robust fourth quarter and full year 2023 financial results, marking a successful first year as a publicly traded company, and provided a positive financial outlook for 2024.
NASDAQ
GE HealthCare Technologies Inc. has announced that its Chief People Officer, Betty D. Larson, will be resigning from her position effective March 21, 2024.